Notal Vision operates the Notal Vision Diagnostic Clinic and provides remote patient monitoring services that extend retinal disease management from clinic to home. Its ForeseeHome AMD Monitoring Program is an FDA-cleared service with Medicare coverage that monitors intermediate dry AMD patients and has demonstrated clinical utility in the HOME Study. The company is developing a Home OCT system that enables technician-free, self-guided OCT testing at home and pairs scans with the proprietary Notal OCT Analyzer (NOA) machine-learning algorithm for automated analysis. Notal Vision plans to commercialize the Home OCT monitoring program to support detection and management of wet AMD and other exudative retinal diseases. The company provides physicians an online portal with B-scan images and annotated fluid locations and aims to build referral partnerships with ophthalmologists and optometrists to expand its service footprint. The announced financing is intended to support commercial growth of ForeseeHome and the go-to-market strategy for the Home OCT pipeline. Notal Vision operates the ForeseeHome AMD Monitoring Program, an FDA-cleared diagnostic that monitors visual changes in patients at risk of vision loss from undiagnosed wet AMD. The company runs the Notal Vision Diagnostic Clinic and offers a platform for engaging patients with high-volume, AI-enabled analyses of personalized health data to improve vision outcomes and reduce treatment burden. Notal is developing a Home OCT platform that received FDA Breakthrough Device designation at the end of 2018 and is intended to enable technician-free, self-guided OCT testing at home for exudative AMD patients. Its in-house Notal OCT Analyzer (NOA), a proprietary machine-learning algorithm, performs automated analysis of Home OCT scans and notifies physicians when physician-specified changes in disease activity are detected. The company raised $25M in funding and plans to use the proceeds to drive commercial growth of the ForeseeHome program and to advance R&D for pipeline technologies, including the Home OCT. Led by CEO Kester Nahen, PhD., Notal Vision is based in Manassas, Virginia.

Total raised

$25M

Funding rounds

2

Latest round

Equity

Latest activity

Dec 2019